Effect of monophosphoryl lipid A (MPL®) on T-helper cells when administered as an adjuvant with pneumocococcal–CRM197 conjugate vaccine in healthy toddlers

This publication has 26 references indexed in Scilit:

• Mechanisms of Monophosphoryl Lipid A Augmentation of Host Responses to Recombinant HagB fromPorphyromonas gingivalis
  Infection and Immunity, 2002
• Monophosphoryl Lipid A (MPL) Formulations for the Next Generation of Vaccines
  Methods, 1999
• Adjuvants—a classification and review of their modes of action
  Published by Elsevier ,1998
• Adjuvants influence the quantitative and qualitative immune response in BALBc mice immunized with respiratory syncytial virus FG subunit vaccine
  Vaccine, 1997
• Safety, Immunogenicity, and Efficacy of Plasmodium falciparum Repeatless Circumsporozoite Protein Vaccine Encapsulated in Liposomes
  The Journal of Infectious Diseases, 1996
• Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides
  Vaccine, 1995
• Boosting immune response with a candidate varicella-zoster virus glycoprotein subunit vaccine
  Vaccine, 1995
• A Comparison of the Immunomodulating Properties of Two Forms of Monophosphory1 Lipid A Analogues
  Journal of Immunotherapy, 1991
• Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: The role of endogenous interleukin 1 in proliferative responses
  Cellular Immunology, 1989
• DURATION OF IMMUNITY AFTER ACTIVE IMMUNISATION AGAINST TETANUS
  The Lancet, 1969